Vincristine neurotoxicity in the presence of hereditary neuropathy.
Trobaugh-Lotrario
Angela D
AD
Section of Pediatric Hematology/Oncology, The Children's Hospital of Denver, University of Colorado School of Medicine, USA.
Smith
Amy A
AA
Odom
Lorrie F
LF
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D002607:Charcot-Marie-Tooth Disease / Q000150:complications / Q000175:diagnosis; D002675:Child, Preschool; D003937:Diagnosis, Differential; D020275:Guillain-Barre Syndrome / Q000150:complications / Q000175:diagnosis; D006801:Humans; D008297:Male; D018908:Muscle Weakness / Q000139:chemically induced*; D009431:Neural Conduction / Q000187:drug effects*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects*
D000972:Antineoplastic Agents, Phytogenic; D014750:Vincristine